Larvol Delta - Early-Results-of-BetterLife-Preclinical-Study-Showing-AP003-rhIFNa2b-has-Similar-Potent-Efficacy-Against-Different-Variants-of-COVID19

AntiCovir (interferon a2b inhalation) - BetterLife Pharma

https://www.globenewswire.com/news-release/2021/07/15/2263510/0/en/Early-Results-of-BetterLife-Preclinical-Study-Showing-AP-003-rhIFNa2b-has-Similar-Potent-Efficacy-Against-Different-Variants-of-COVID-19.html

Jul 15, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next